Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Monocytes from male patients with ankylosing spondylitis display decreased osteoclastogenesis and decreased RANKL/OPG ratio.

Caparbo VF, Saad CGS, Moraes JC, de Brum-Fernandes AJ, Pereira RMR.

Osteoporos Int. 2018 Jul 13. doi: 10.1007/s00198-018-4629-z. [Epub ahead of print]

PMID:
30006885
2.

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.

Pelletier JP, Raynauld JP, Beaulieu AD, Bessette L, Morin F, de Brum-Fernandes AJ, Delorme P, Dorais M, Paiement P, Abram F, Martel-Pelletier J.

Arthritis Res Ther. 2016 Nov 3;18(1):256.

3.

Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.

Carrier N, Marotta A, de Brum-Fernandes AJ, Liang P, Masetto A, Ménard HA, Maksymowych WP, Boire G.

Arthritis Res Ther. 2016 Feb 1;18:37. doi: 10.1186/s13075-016-0935-z.

4.

Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.

Challener GJ, Jones JD, Pelzek AJ, Hamilton BJ, Boire G, de Brum-Fernandes AJ, Masetto A, Carrier N, Ménard HA, Silverman GJ, Rigby WFC.

J Rheumatol. 2016 Feb;43(2):273-281. doi: 10.3899/jrheum.150179. Epub 2015 Dec 15.

5.

Depressive symptoms predict future simple disease activity index scores and simple disease activity index remission in a prospective cohort of patients with early inflammatory polyarthritis.

Leblanc-Trudeau C, Dobkin PL, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Masetto A, Boire G.

Rheumatology (Oxford). 2015 Dec;54(12):2205-14. doi: 10.1093/rheumatology/kev272. Epub 2015 Jul 25.

PMID:
26209789
6.

Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels.

Jones JD, Hamilton BJ, Challener GJ, de Brum-Fernandes AJ, Cossette P, Liang P, Masetto A, Ménard HA, Carrier N, Boyle DL, Rosengren S, Boire G, Rigby WF.

Arthritis Res Ther. 2014 Apr 25;16(2):R103. doi: 10.1186/ar4552.

7.

Cytosolic phospholipase A2 and eicosanoids modulate life, death and function of human osteoclasts in vitro.

Allard-Chamard H, Dufort P, Haroun S, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 2014 Apr;90(4):117-23. doi: 10.1016/j.plefa.2013.12.009. Epub 2014 Jan 1.

PMID:
24508380
8.

Secreted phospholipase A2 type II is present in Paget's disease of bone and modulates osteoclastogenesis, apoptosis and bone resorption of human osteoclasts independently of its catalytic activity in vitro.

Allard-Chamard H, Haroun S, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 2014 Feb-Mar;90(2-3):39-45. doi: 10.1016/j.plefa.2013.12.007. Epub 2013 Dec 27.

PMID:
24411720
9.

Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways.

Yue L, Haroun S, Parent JL, de Brum-Fernandes AJ.

Bone. 2014 Mar;60:112-21. doi: 10.1016/j.bone.2013.12.011. Epub 2013 Dec 15.

PMID:
24345643
10.

Predictors of pain for patients with early inflammatory polyarthritis.

Dobkin PL, Liu A, Abrahamowicz M, Carrier N, de Brum-Fernandes AJ, Cossette P, Boire G.

Arthritis Care Res (Hoboken). 2013 Jun;65(6):992-9. doi: 10.1002/acr.21923.

11.

Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study.

Durand M, Komarova SV, Bhargava A, Trebec-Reynolds DP, Li K, Fiorino C, Maria O, Nabavi N, Manolson MF, Harrison RE, Dixon SJ, Sims SM, Mizianty MJ, Kurgan L, Haroun S, Boire G, de Fatima Lucena-Fernandes M, de Brum-Fernandes AJ.

Arthritis Rheum. 2013 Jan;65(1):148-58. doi: 10.1002/art.37722.

12.

Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway.

Yue L, Durand M, Lebeau Jacob MC, Hogan P, McManus S, Roux S, de Brum-Fernandes AJ.

Bone. 2012 Sep;51(3):338-46. doi: 10.1016/j.bone.2012.06.003. Epub 2012 Jun 12.

PMID:
22705147
13.

Utility and feasibility of musculoskeletal ultrasonography (MSK US) in rheumatology practice in Canada: needs assessment.

Larché MJ, McDonald-Blumer H, Bruns A, Roth J, Khy V, de Brum-Fernandes AJ, Wakefield RJ, Brown AK, Bykerk V.

Clin Rheumatol. 2011 Oct;30(10):1277-83. doi: 10.1007/s10067-011-1743-0. Epub 2011 Apr 12.

PMID:
21484225
14.

The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.

Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ.

Bone. 2011 Mar 1;48(3):588-96. doi: 10.1016/j.bone.2010.10.167. Epub 2010 Oct 17.

PMID:
20959150
15.

Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies.

Guzian MC, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Ménard HA, Boire G.

Arthritis Care Res (Hoboken). 2010 Nov;62(11):1624-32. doi: 10.1002/acr.20288. Epub 2010 Jul 8.

16.

Increased concentrations of prostaglandin D2 during post-fracture bone remodeling.

Gallant MA, Chamoux E, Bisson M, Wolsen C, Parent JL, Roux S, de Brum-Fernandes AJ.

J Rheumatol. 2010 Mar;37(3):644-9. doi: 10.3899/jrheum.090622. Epub 2010 Jan 15.

PMID:
20080921
17.

Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: identification of a recycling motif.

Roy SJ, Parent A, Gallant MA, de Brum-Fernandes AJ, Stanková J, Parent JL.

Eur J Pharmacol. 2010 Mar 25;630(1-3):10-8. doi: 10.1016/j.ejphar.2009.12.022. Epub 2009 Dec 24.

PMID:
20035740
18.

CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.

Néron S, Boire G, Dussault N, Racine C, de Brum-Fernandes AJ, Côté S, Jacques A.

Arch Immunol Ther Exp (Warsz). 2009 Nov-Dec;57(6):447-58. doi: 10.1007/s00005-009-0048-3. Epub 2009 Oct 29.

PMID:
19866343
19.

Cardiovascular safety of celecoxib in acute myocardial infarction patients: a nested case-control study.

Vanasse A, de Brum-Fernandes AJ, Courteau J.

Heart Int. 2009 Jun 30;4(1):e10. doi: 10.4081/hi.2009.e10.

20.

Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models.

Siqueira JM, Gazola AC, Farias MR, Volkov L, Rivard N, de Brum-Fernandes AJ, Ribeiro-do-Valle RM.

Cancer Chemother Pharmacol. 2009 Aug;64(3):529-38. doi: 10.1007/s00280-008-0901-9. Epub 2009 Jan 30.

PMID:
19184021
21.

Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts.

Durand M, Gallant MA, de Brum-Fernandes AJ.

J Bone Miner Res. 2008 Jul;23(7):1097-105. doi: 10.1359/jbmr.080228.

22.

The inducible nitric-oxide synthase modulates endothelin-1-dependent release of prostacyclin and inhibition of platelet aggregation ex vivo in the mouse.

Carrier E, Brochu I, de Brum-Fernandes AJ, D'Orléans-Juste P.

J Pharmacol Exp Ther. 2007 Dec;323(3):972-8. Epub 2007 Sep 20.

23.

PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury.

Saleem S, Zhuang H, de Brum-Fernandes AJ, Maruyama T, Narumiya S, Doré S.

Eur J Neurosci. 2007 Jul;26(1):73-8. Epub 2007 Jun 16.

24.

Anti-inflammatory effects of a triterpenoid isolated from Wilbrandia ebracteata Cogn.

Siqueira JM Jr, Peters RR, Gazola AC, Krepsky PB, Farias MR, Rae GA, de Brum-Fernandes AJ, Ribeiro-do-Valle RM.

Life Sci. 2007 Mar 20;80(15):1382-7. Epub 2007 Jan 11.

PMID:
17286991
25.

Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.

Gallant MA, Slipetz D, Hamelin E, Rochdi MD, Talbot S, de Brum-Fernandes AJ, Parent JL.

Eur J Pharmacol. 2007 Feb 28;557(2-3):115-23. Epub 2006 Dec 5.

PMID:
17207480
27.

Prostaglandin production by human osteoclasts in culture.

Hackett JA, Allard-Chamard H, Sarrazin P, de Fatima Lucena M, Gallant MA, Fortier I, Nader M, Parent JL, Bkaily G, de Brum-Fernandes AJ.

J Rheumatol. 2006 Jul;33(7):1320-8. Epub 2006 Jun 1.

PMID:
16758505
28.

Implication of prostaglandin receptors in the accumulation of osteoprotegerin in human osteoblast cultures.

Samadfam R, Gallant MA, Miousse MC, Parent JL, de Brum-Fernandes AJ.

J Rheumatol. 2006 Jun;33(6):1167-75.

PMID:
16755666
29.

Prostaglandin EP4 receptor agonist protects against acute neurotoxicity.

Ahmad AS, Ahmad M, de Brum-Fernandes AJ, Doré S.

Brain Res. 2005 Dec 20;1066(1-2):71-7. Erratum in: Brain Res. 2006 Jun 13;1094(1):217.

PMID:
16360658
30.

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA.

Arthritis Res Ther. 2005;7(3):R592-603. Epub 2005 Mar 17.

31.

Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.

Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, de Brum-Fernandes AJ.

J Bone Miner Res. 2005 Apr;20(4):672-81. Epub 2004 Dec 6.

32.

Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.

Giguère V, Gallant MA, de Brum-Fernandes AJ, Parent JL.

Eur J Pharmacol. 2004 Jun 21;494(1):11-22.

PMID:
15194446
33.

Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: differences in foetal, adult normal, osteoporotic and pagetic bone.

Fortier I, Gallant MA, Hackett JA, Patry C, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 2004 May;70(5):431-9.

PMID:
15062845
34.

Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.

Battersby S, Critchley HO, de Brum-Fernandes AJ, Jabbour HN.

Reproduction. 2004 Jan;127(1):79-86.

35.

Nitric oxide and cyclooxygenase may participate in the analgesic and anti-inflammatory effect of the cucurbitacins fraction from Wilbrandia ebracteata.

Peters RR, Baier Krepsky P, Siqueira-Junior J, da Silva Rocha JC, Marques Bezerra M, de Albuquerque Ribeiro R, de Brum-Fernandes AJ, Rocha Farias M, Castro da Rocha FA, Ribeiro-do-Valle RM.

Life Sci. 2003 Sep 12;73(17):2185-97.

PMID:
12927589
36.

Evidence that peroxynitrite affects human osteoblast proliferation and differentiation.

da Rocha FA, de Brum-Fernandes AJ.

J Bone Miner Res. 2002 Mar;17(3):434-42.

37.

A comparative study of the antipyretic effects of indomethacin and dipyrone in rats.

De Souza GE, Cardoso RA, Melo MC, Fabricio AS, Silva VM, Lora M, De Brum-Fernandes AJ, Rae GA, Ferreira SH, Zampronio AR.

Inflamm Res. 2002 Jan;51(1):24-32.

PMID:
11852909
38.

Immunohistochemical localization of the prostacyclin receptor (IP) human bone.

Fortier I, Patry C, Lora M, Samadfan R, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 2001 Aug;65(2):79-83.

PMID:
11545623
39.

Characterization of the prostaglandin receptors in human osteoblasts in culture.

Sarrazin P, Bkaily G, Haché R, Patry C, Dumais R, Rocha FA, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 2001 Mar;64(3):203-10.

PMID:
11334557
40.

Anti-inflammatory effects of the products from Wilbrandia ebracteata on carrageenan-induced pleurisy in mice.

Peters RR, Saleh TF, Lora M, Patry C, de Brum-Fernandes AJ, Farias MR, Ribeiro-do-Valle RM.

Life Sci. 1999;64(26):2429-37.

PMID:
10403502
41.

Systematic pharmacological approach to the characterization of NSAIDs.

Lora M, Denault JB, Leduc R, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 1998 Jul;59(1):55-62.

PMID:
9758208
42.
43.

Induction of cyclooxygenase-2 by parathyroid hormone in human osteoblasts in culture.

Maciel FM, Sarrazin P, Morisset S, Lora M, Patry C, Dumais R, de Brum-Fernandes AJ.

J Rheumatol. 1997 Dec;24(12):2429-35.

PMID:
9415654
44.

Functional IL-2 receptors are expressed by rat lung type II epithelial cells.

Lesur O, Arsalane K, Bérard J, Mukuna JP, de Brum-Fernandes AJ, Lane D, Rola-Pleszczynski M.

Am J Physiol. 1997 Sep;273(3 Pt 1):L495-503.

PMID:
9316482
45.

Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin.

Lora M, Morisset S, Ménard HA, Leduc R, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 1997 May;56(5):361-7.

PMID:
9175172
46.

New perspectives for nonsteroidal antiinflammatory therapy.

de Brum-Fernandes AJ.

J Rheumatol. 1997 Feb;24(2):246-8. Review. No abstract available.

PMID:
9034978
47.

Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.

de Brum-Fernandes AJ, Morisset S, Bkaily G, Patry C.

Br J Pharmacol. 1996 Aug;118(7):1597-604.

48.

Leukotriene receptors in HL-60 cells differentiated into eosinophils, monocytes and neutrophils.

Patry C, Müller E, Laporte J, Rola-Pleszczynski M, Sirois P, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 1996 May;54(5):361-70.

PMID:
8832765
49.

Mutations of two adjacent amino acids generate inactive and constitutively active forms of the human platelet-activating factor receptor.

Parent JL, Le Gouill C, de Brum-Fernandes AJ, Rola-Pleszczynski M, Stanková J.

J Biol Chem. 1996 Apr 5;271(14):7949-55.

50.

Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Sirois MG, de Lima WT, de Brum Fernandes AJ, Johnson RJ, Plante GE, Sirois P.

Br J Pharmacol. 1994 Apr;111(4):1111-6.

Supplemental Content

Loading ...
Support Center